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A central feature of TB pathogenesis is the formation of Mycobacterium tuberculosis latent infections that
can persist for decades. Nitric oxide produced by infected lung macrophages promotes expression of
genes associated with dormancy, and impaired nitric oxide production can lead to reactivation of latent
disease. Recently, WhiB1 was identiﬁed as a nitric oxide-responsive transcription factor. Here it is shown
that apo-WhiB1 binds to groEL2 (Rv0440) promoter DNA. Apo-WhiB1 inhibited transcription from the
groEL2 promoter in vitro and the transcript start was located w181 bases upstream of the groEL2 start
codon. Electrophoretic mobility shift assays with sub-fragments of the groEL2 promoter indicated that
the complete Rv0439c-Rv0440 intergenic region was required for WhiB1 binding, suggesting that this
region possessed more than one WhiB1-binding site. DNase I footprinting identiﬁed a WhiB1-binding
region that overlapped the 35 element of the groEL2 promoter. The CRP-family transcription factor Cmr
(Rv1675c) was shown to bind the groEL2 promoter and activate transcription in vitro in the presence or
absence of cAMP. Therefore, it is suggested that WhiB1 acts to oppose Cmr-mediated cAMP-independent
activation of groEL2 expression in the presence of nitric oxide by promoter occlusion.
 2012 Elsevier Ltd. Open access under CC BY license.1. Introduction
The etiological agent of tuberculosis, Mycobacterium tubercu-
losis, causes the deaths of two million people annually.1 Its efﬁ-
ciency as a pathogen is partially due to the ability to adapt to the
disparate environments encountered during the process of infec-
tion. The preferred niche forM. tuberculosis is the lung macrophage
where it is exposed to reactive oxygen species (e.g. superoxide),
reactive nitrogen species (e.g. nitric oxide), low pH, toxic peptides
and fatty acids, hypoxia and essential element starvation.2 During
transmission, M. tuberculosis must cope with the stresses (e.g. low
temperature, dehydration) associated with residence in the droplet
nuclei that are expelled from an infected host. Adaptation to these
changing environments requires the reprogramming of
M. tuberculosis gene expression coordinated byw190 transcription
regulators responding to diverse signals.3 Recently, M. tuberculosis
WhiB1 (a member of the WhiB-like (Wbl) protein family) was
shown to be a nitric oxide-responsive transcription factor.4e7
Exposure of M. tuberculosis to nitric oxide initiates the dormancy
gene expression program that may contribute to the establishmentx: þ44 114 222 2800.
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 license.of latent TB infections.8 Hence the inﬂuence of WhiB1 on
M. tuberculosis gene expression is potentially signiﬁcant in TB
pathogenesis. Several states of the WhiB1 protein have been
identiﬁed. The [4Fee4S] form of WhiB1 (holo-form) was incapable
of binding at the whiB1 promoter, whereas the reduced and
oxidized forms of apo-WhiB1, as well as nitric oxide-treated holo-
WhiB1 (nitrosylated-form) were able to speciﬁcally bind DNA.7
Thus, the presence or absence and state of the WhiB1 ironesulfur
cluster (nitrosylated or non-nitrosylated) as well as the redox
state of apo-WhiB1 inﬂuence the ability to bind DNA and regulate
transcription.7 It is not yet clear whether the different DNA-binding
forms of WhiB1, oxidized and reduced apo-WhiB1 and nitrosylated
WhiB1, elicit the same transcriptional responses or recognize the
same DNA targets. Nevertheless, because the M. tuberculosis whiB1
gene is essential, the inﬂuence of this regulator in the reprogram-
ming of gene expression is of considerable interest.7 However, until
the present work, the only recognized WhiB1 target was the whiB1
promoter itself.7 Here a secondWhiB1-regulated gene is identiﬁed;
groEL2.
M. tuberculosis has two chaperonin genes: groEL1 (Rv3417c) is
located downstream of whiB3 (Rv3416), which, like whiB1, encodes
a member of the Wbl protein family; and groEL2 (Rv0440). The
groEL1 gene is dispensable, whereas groEL2 is essential.9 The
paradigm for chaperonin function is the sequestration of unfolded
Figure 1. WhiB1 binds at Rv0439c-Rv0440 (groEL2) intergenic region. (A) Radiolabeled
Rv0439c-Rv0440 (groEL2) intergenic DNA was incubated with increasing concentra-
tions of apo-WhiB1 before separation of protein-DNA complexes by electrophoresis.
Lane 1, no protein; lanes 2e6 contain, 2.5, 5, 10, 20 and 40 mM apo-WhiB1, respectively.
(B) The ironesulfur form of WhiB1 (holo-WhiB1) does not bind at the Rv0439c-Rv0440
(groEL2) intergenic region. Lane 1, no protein; lane 2, apo-WhiB1 (20 mM); lane 3, holo-
WhiB1 (20 mM). WhiB1 does not bind at the ahpC promoter. Lane 4, no protein; lane 5,
apo-WhiB1 (20 mM); lane 6, holo-WhiB1 (20 mM). (C) Apo-WhiB1 binding to radio-
labeled Rv0439c-Rv0440 (groEL2) DNA is inhibited by unlabeled Rv0439c-Rv0440
(groEL2) DNA but not by unlabeled rpfA promoter DNA. Lane 1, no protein; lanes 2e7
apo-WhiB1 (20 mM) in the absence (lanes 2 and 5), or presence of 100- and 50-fold
molar excess unlabeled Rv0439c-Rv0440 (groEL2) DNA (lanes 3 and 6) or unlabeled
rpfA promoter DNA (lanes 4 and 7). The locations of the free DNA (groEL2, ahpC) and
the DNA-apo-WhiB1 complex (apo-WhiB1-groEL2) are indicated.
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heptameric rings of GroEL capped by GroES where refolding can
occur in a process that requires ATP hydrolysis.10 However, the
isolated GroEL2 protein from M. tuberculosis does not form such
a structure but is dimeric and lacks ATPase activity.11 Furthermore,
the GroEL2 protein is highly antigenic and modulates the immune
environment by stimulating the release of the cytokines
interleukin-10 and tumor necrosis factor-a from monocytes in
a CD14-independent manner.12 Thus, the M. tuberculosis GroEL2
chaperonin deviates signiﬁcantly from the established paradigm.13
Expression of groEL2was increased upon heat shock in a process
involving the repressor protein HrcA, and lowered in response to
Mg(II)-starvation and in a cmr (Rv1675c) mutant 2 h into macro-
phage infection; cmr encodes a member of the cyclic-AMP receptor
protein (CRP) family of transcription factors that is proposed to
regulate cAMP-induced genes in macrophages.14e17 Here the nitric
oxide-responsive transcription regulator WhiB1 is identiﬁed as
a repressor of groEL2 expression.
2. Materials and methods
2.1. Isolation of proteins
WhiB1 and Mycobacterium smegmatis RNA polymerase were
isolated as described previously.7 Where indicated WhiB1 was
treated with nitric oxide (20:1 molar ratio of nitric oxide:WhiB1 for
10 min at 20 C) to activate DNA-binding. The Cmr (Rv1675c)
protein was overproduced with a N-terminal hexa-His-tag in
Escherichia coli from plasmid (pGS2103; a pET28a derivative) and
isolated by afﬁnity chromatography on a 1 ml Hi-Trap Chelating
column (GE Healthcare) using the manufacturer’s standard
protocol.
2.2. Electrophoretic mobility shift assays and in vitro transcription
reactions
Electrophoretic mobility shift assays (EMSA) were as described
previously.7 Radiolabeled Rv0439c-Rv0440 intergenic DNA (groEL2)
or fragments thereof, or ahpC promoter DNA (w1.6 nM) were
incubated with 0e40 mMHis6-WhiB1 in the presence of 40mM Tris
pH 8.0, 1 mM EDTA, 100 mM NaCl, 1 mM DTT, 10 mM MgCl2,
0.25 mg ml1 bovine serum albumin and 1 mg calf thymus DNA, for
5 min on ice. For the analysis of CmreDNA interactions, the protein
(0e8 mM) was pre-incubated with the groEL2 promoter DNA for
10 min at 25 C in the same buffer as above in the presence or
absence of 1 mM cAMP. The resulting complexes were then sepa-
rated on 6% polyacrylamide gels. In vitro transcription reactions
were assembled and quantiﬁed as described previously except that
the indicated fragments of the Rv0439c-Rv0440 (groEL2) intergenic
region were used.7
2.3. DNase I footprinting
Radiolabeled Rv0439c-Rv0440 (groEL2) intergenic region
(w60 ng) was incubated with 20 mMHis6-WhiB1 in the presence of
40 mM Tris pH 7.5, 50 mMNaCl, 10 mMMgCl2, 0.5 mM EDTA, 1 mM
DTT and 0.25 mgml1 bovine serum albumin for 10 min on ice. The
complexes were then digested with 1 unit of DNase I for 15e60 s at
25 C. Reactions were stopped by the addition of 200 ml 0.3 M
sodium acetate (pH 5.2) containing 20 mM EDTA, followed by
phenol/chloroform extraction. The DNA was ethanol-precipitated
and resuspended in loading buffer (80% v/v formamide, 0.1% w/v
SDS, 10% v/v glycerol, 8 mM EDTA, 0.1% w/v bromophenol blue,
0.1% w/v xylene cyanol) for electrophoretic fractionation on 6%
polyacrylamideeurea gels and autoradiographic analysis. Maxamand Gilbert G tracks of the DNA fragments were used to provide
a calibration.18
3. Results
3.1. Apo-WhiB1 binds at the Rv0439c-groEL2 intergenic region
Several M. tuberculosis promoter regions were tested as targets
for regulation by apo-WhiB1. Binding was detected in electropho-
retic mobility shift assays (EMSA) when the Rv0439c-Rv0440
(groEL2) intergenic region was the target (Figure 1A). As previously
observed with the whiB1 promoter itself (Ref. 7), binding at the
Rv0439c-Rv0440 (groEL2) intergenic region saturated over a narrow
range of apo-WhiB1 concentration, consistent with cooperative
interactions with the DNA, and implying the presence of more than
one apo-WhiB1 binding site. Nevertheless, the apo-WhiB1 inter-
actions were judged to be speciﬁc because binding was not
detected when the ahpC promoter was used (Figure 1B, lanes 4e6)
or the rpfA promoter (Ref. 7), andwhereas the formation of the apo-
WhiB1 complex with radiolabeled Rv0439c-Rv0440 (groEL2) inter-
genic DNA was inhibited by excess (100- and 50-fold) unlabeled
Rv0439c-Rv0440 (groEL2) competitor DNA (Figure 1C, lanes 3 and 6)
Figure 2. Apo-WhiB1 inhibits transcription of groEL2 in vitro. Reactions in lanes 1, 3
and 5 contained: 0.1 pmole of template DNA (lane 1, template A; lane 3, template B;
lane 5, template C, as shown in the upper panel), 1 pmole M. smegmatis RNA poly-
merase, 40 mM TriseCl pH 8.0, 10 mM MgCl2, 70 mM NaCl, 1 mM EDTA, 1 mM DTT,
250 mg ml1 bovine serum albumin, 5% glycerol. Reactions in lanes 2 (template A), 4
(template B) and 6 (template C) were pre-incubated with apo-WhiB1 (20 mM) for
10 min at 37 C. The sizes of the standard RNA molecules (lanes M) used to calibrate
the gel are indicated.
Figure 3. Apo-WhiB1 binds at a site overlapping the 35 element of the groEL2 promoter
incubated with nitric oxide-treated WhiB1 before separation of protein-DNA complexes by e
and region protected by apo-WhiB1 in DNase I footprints (hatched box) are indicated. Lane
(F1); lanes 3 and 4, Rv0439c-Rv0440 (groEL2) sub-fragment extending from 116 to e16
toþ34 bp (F3); lanes 7 and 8, Rv0439c-Rv0440 (groEL2) sub-fragment extending from 15 to
protein; lanes 2, 4, 6 and 8, nitric oxide-treated WhiB1 (20 mM). The locations of the free DN
footprint of the groEL2 promoter: lane 1, no apo-WhiB1, lanes 2 and 3, apo-WhiB1 (20 mM), l
is indicated by the open rectangle; a hypersensitive site (27) is arrowed. The closed rect
marked by þ1. The DNA sequence of the groEL2 promoter is shown on the right. The region
transcript start (þ1) is in bold type.
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(Figure 1C, lanes 4 and 7). Furthermore, the ironesulfur holo-form
of WhiB1 did not bind Rv0439c-Rv0440 (groEL2) intergenic DNA
(Figure 1B, lane 3). It was therefore concluded that apo-WhiB1
speciﬁcally binds at the Rv0439c-Rv0440 (groEL2) intergenic
region and that binding was modulated by the presence/absence of
the ironesulfur cluster.3.2. Apo-WhiB1 inhibits transcription of groEL2
In vitro transcription assays were used to determine the
consequences of apo-WhiB1 binding at the Rv0439c-Rv0440
(groEL2) intergenic region. Three templates were designed to
distinguish which of the divergent Rv0439c and groEL2 promoters
was active and potentially regulated by WhiB1 (Figure 2). If the
Rv0439c promoter was active, templates A and B would yield the
same sized product and template Cwould yield a product 300 bases
smaller than templates A and B. If the groEL2 promoter was active
then templates A and C would yield the same sized product and
template B would yield a product 100 bases smaller than that
produced by templates A and C (Figure 2). The experiments showed
that templates A and C yielded transcripts ofw290 bases, and the
template C transcript was w190 bases (Figure 2). Thus it was
concluded that the groEL2 promoter is active in the presence of
M. smegmatis sA-RNA polymerase. Furthermore, the sizes of the
products identiﬁed the location of the groEL2 transcript start point
at w181 bases upstream of the start codon, a position associated
with potential sA 10 (AAGAAT, 4/6 matches to the consensus
TATAMT) and35 elements (TGCACT, 4/6matches to the consensus. (A) Radiolabeled fragments of Rv0439c-Rv0440 (groEL2) intergenic DNA (F1e4) were
lectrophoresis. The DNA fragments are shown on the right. The transcript start (arrow)
s 1 and 2, Rv0439c-Rv0440 (groEL2) intergenic region extending from 116 to þ181 bp
bp (F2); lanes 5 and 6, Rv0439c-Rv0440 (groEL2) sub-fragment extending from 116
þ181 bp (F4). Numbering is relative to the groEL2 transcript start. Lanes 1, 3, 5 and 7, no
A species (F1eF4) and the WhiB1 complexes (WhiB1-groEL2) are indicated. (B) DNase I
ane M, Maxam and Gilbert G track. The region of DNA protected from DNase I digestion
angles indicate the locations of the 35 and 10 elements and the transcript start is
of apo-WhiB1 protection is boxed, the 35 and 10 elements are underlined and the
Figure 4. Cmr activates transcription of groEL2. (A) Cmr binds at the groEL2 promoter.
Radiolabeled groEL2 promoter DNA was incubated with increasing concentrations of
Cmr (Rv1675c) before separation of protein-DNA complexes by electrophoresis. Lane 1,
no protein; lanes 2e7 contain, 0.25, 0.5, 1.0, 2.0, 4.0 and 8.0 mM Cmr, respectively. (B)
Cmr activates groEL2 transcription in vitro. A representative autoradiograph is shown.
Lane 1, 200 base RNA marker. In vitro transcription reactions contained 0.1 pmole of
groEL2 promoter, 1 pmole M. smegmatis RNA polymerase, 40 mM TriseCl pH 8.0,
10 mM MgCl2, 70 mM NaCl, 1 mM EDTA, 1 mM DTT, 250 mg ml1 bovine serum
albumin, 5% glycerol with increasing amounts of Cmr: lanes 2 and 7, 0 mM; lanes 3 and
8, 0.1 mM; lanes 4 and 9, 0.2 mM; lanes 5 and 10, 0.5 mM; and lanes 6 and 11, 1.0 mM.
Reactions in lanes 7e11 contained 1 mM cAMP. The groEL2 transcript and the loading
control are indicated. (C) The amounts of groEL2 transcript, in the presence (ﬁlled bars)
or absence (open bars) of 1 mM cAMP, in each of the reactions shown in (B) were
quantiﬁed using ImageMaster software (GE Healthcare) and plotted as a histogram.
Typically 1.0 mM Cmr resulted in w3-fold activation of groEL2 transcription over the
basal level.
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product from all three transcripts was severely reduced (w10-fold)
when the in vitro transcription reactions contained apo-WhiB1
(Figure 2, lanes 2, 4 and 6). Therefore, it was concluded that
WhiB1 represses transcription of M. tuberculosis groEL2.
3.3. DNase I footprinting suggests that apo-WhiB1 represses groEL2
transcription by promoter occlusion
To better deﬁne the DNA elements required for apo- and
nitrosylated-WhiB1 binding at the groEL2 promoter, sub-fragments
of the Rv0439c-Rv0440 (groEL2) intergenic region were used as the
targets in EMSAs. Whilst the mobility of the complete intergenic
region (116 to þ181 bp relative to the groEL2 transcript start) was
retarded by both apo- (Figure 1) and nitric oxide-treated WhiB1
(Figure 3A), sub-fragments encompassing 116 to 16, 116
to þ34 or 15 to þ181 bp relative to the groEL2 transcript start
were not retarded by either apo- (not shown) or nitric oxide-
treated WhiB1 (Figure 3A). These data indicate that WhiB1
requires the complete Rv0439c-Rv0440 intergenic region to form
a stable nucleoprotein complex. DNase I footprinting identiﬁed one
locus of apo-WhiB1 binding at the groEL2 promoter as a 25 bp
region of protection situated between 26 and 50 relative to the
transcript start with a hypersensitive site at 27 (Figure 3B). Thus,
the apo-WhiB1 footprint at the groEL2 promoter was located in
a similar position to that observed at the whiB1 promoter, i.e.
overlapping the 35 element.7 Therefore, the simplest explanation
to account for the in vitro transcription data is that apo-WhiB1
represses groEL2 expression by promoter occlusion.
3.4. Cmr activates groEL2 transcription
M. tuberculosis Cmr (Rv1675c) is a member of the CRP family of
transcription factors that is required for cAMP-induced protein
expression, including GroEL2, in macrophages.16 This suggested
that Cmr activates groEL2 expression. Binding of Cmr to the groEL2
promoter was shown by Gazdik et al. (Ref. 16) and was conﬁrmed
here (Figure 4A). Cmr binding at the groEL2 promoter was unaf-
fected by the addition of 1 mM cAMP (not shown). Transcription of
groEL2 in vitrowas enhancedw3-fold in the presence of 1 mM Cmr
and this activation was independent of cAMP (Figure 4B and C).
Activation of groEL2 transcription by Cmr is consistent with the
previously observed down-regulation of groEL2 expression when
the cmr mutant was allowed to infect macrophages for 2 h.16
4. Discussion
Until this report the only other known target for the nitric oxide-
responsive transcription factor WhiB1 was its own promoter.7 Here
it is shown that WhiB1 represses groEL2 expression. The GroEL2
protein is an essential chaperonin.9 Down-regulation of groEL2
expression by WhiB1 in the presence of nitric oxide should there-
fore inhibit the growth of M. tuberculosis perhaps assisting entry
into the dormant state. Expression of groEL2 is modulated by the
transcription factor Cmr (Rv1675c) and is also induced by cAMP.16,17
The in vitro transcription reactions reported here show that Cmr
activates groEL2 transcription in the absence of cAMP, suggesting
that Cmr does not directly mediate the cAMP effect on groEL2
expression. Like the groEL2 promoter, expression of the other
known target for WhiB1, whiB1, responds to cAMP.19,20 In the latter
case, the mycobacterial CRP protein (Rv3676) acts as a dual regu-
lator of whiB1 expression in response to cAMP, but activation by
cAMP-CRP is inhibited by apo-WhiB1, i.e. WhiB1 negatively auto-
regulates expression.7,20 Hence it is possible that the cAMP-
mediated effects on groEL2 expression observed in vivo arise, atleast in part, from CRP-mediated regulation of whiB1. Nevertheless,
it is clear that both of the WhiB1 targets identiﬁed so far are linked
to cAMP-signaling. It has recently been shown that upon infection
of macrophages, mycobacterium-derived cAMP promotes bacterial
survival by subverting host signaling pathways.21 Moreover, cAMP
is important in M. tuberculosis gene regulation.17,19,20 The interac-
tion between cAMP-responsive regulators and the nitric oxide-
responsive WhiB1 protein might provide a mechanism to inte-
grate the transcriptional response to two important signals asso-
ciated with infection. Furthermore, although only two promoters
(whiB1 and groEL2) have thus far been identiﬁed as WhiB1 targets
both exhibited cooperative binding to sites overlapping the 35
elements of the promoters, resulting in repression of transcription.
These observations suggest that promoter occlusion might be
a common feature of gene regulation by WhiB1. However, it is
apparent that apo-WhiB1 interactions with the groEL2 promoter
region are complex and the complete Rv0439c-Rv0440 intergenic
region is required to form a stable nucleoprotein complex. This
M.R. Stapleton et al. / Tuberculosis 92 (2012) 328e332332suggests the presence of at least two WhiB1-binding sites within
this region and that both the site overlapping the35 element, that
is identiﬁed here, and unidentiﬁed site(s) are required for detect-
ableWhiB1 binding in EMSAs. Protein:DNA interactions of this type
are not unprecedented but usually at least two regulator:DNA
complexes are observed in EMSAs. These complexes result from
binding of the regulator ﬁrst to a high afﬁnity site and then
subsequent cooperative occupation of a low afﬁnity site. In such
cases impairment of the high afﬁnity site abolishes binding to the
low afﬁnity site.22 It appears that detectable WhiB1 binding to the
Rv0439c-Rv0440 intergenic region is dependent on sites of similar
afﬁnity and that binding is highly cooperative.
In conclusion, the work described here reveals new aspects of
the regulation of M. tuberculosis groEL2. Previously, expression of
groEL2 was shown to be controlled by HrcA (derepression in
response to heat shock), by Cmr (activation in response to an
unknown cAMP-related signal), and by Mg(II)-starvation (repres-
sion by a PhoPR-independent mechanism).14e16 Now it is shown
that WhiB1 represses groEL2 in response to signals e nitric oxide,
oxidative stress, iron-starvation e that promote the formation of
the DNA-binding apo- and nitrosylated-forms of WhiB1. An
understanding of the precise interplay between these regulators
and the consequences for groEL2 expression awaits further detailed
biochemical analysis. However, it appears that several signals
associated with the process of infection are sensed and transduced
by integrated gene regulatory circuits to optimize expression of the
essential chaperonin GroEL2.
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